Glycoprotein Analysis via Tandem Mass Spectrometry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying glycoproteins using tandem mass spectrometry face challenges due to the vast number of possible glycan structures, leading to difficulties in database matching and loss of glycan information during enzymatic trimming or analysis, especially for O-glycosylations.
Innovation Solution
A system and method that operates a tandem mass spectrometer to perform both collision-induced dissociation (CID) and electron-based dissociation (ExD) and combines their data to identify glycoproteins, utilizing CID to analyze glycan structures and ExD to determine peptide sequences, thereby reconstructing the entire glycoprotein.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If enzymatic trimming is used to simplify glycan analysis, then analysis complexity is reduced, but glycan information is lost
Solution Approach 1:
The patent extracts and separates glycan analysis from peptide analysis by using two different dissociation methods. CID is used to analyze glycan structures by producing glycan-specific fragment ions, while ExD is used to analyze peptide sequences. This extraction allows glycan information to be obtained without enzymatic trimming while keeping peptide analysis separate and simplified.
Solution Approach 2:
The patent segments the glycoprotein analysis into two distinct analytical pathways: one for glycan structure determination using CID and another for peptide sequence determination using ExD. This segmentation allows each method to be optimized for its specific purpose without the need for enzymatic trimming that would compromise glycan information.
2Reliability
If database matching is performed with all possible glycan structures, then identification completeness is improved, but computational complexity increases
Solution Approach 1:
The patent extracts glycan mass information from CID spectra and uses it to generate targeted candidate glycopeptide lists. This extraction approach avoids the need to search against databases containing all possible glycan structures, significantly reducing computational complexity while maintaining identification completeness by focusing only on relevant candidates.
Solution Approach 2:
The patent performs preliminary analysis using CID to determine glycan masses before proceeding to peptide sequence determination. This preliminary action allows the system to pre-filter candidate glycopeptides based on observed glycan masses, reducing the computational burden of subsequent database searching and matching operations.
3Device complexity
If a single dissociation method is used, then instrument simplicity is maintained, but information completeness is reduced
Solution Approach 1:
The patent implements a tandem mass spectrometer system with multi-functionality, capable of performing both CID and ExD using the same instrument platform. This allows the system to obtain both glycan structure information (via CID) and peptide sequence information (via ExD) without requiring multiple separate instruments, maintaining instrument simplicity while achieving information completeness.
Solution Approach 2:
The patent merges two different dissociation methods (CID and ExD) into a single integrated workflow. By combining the strengths of both methods within one instrument system, the patent achieves comprehensive glycoprotein characterization including both glycan and peptide information while avoiding the need for separate analytical systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively addresses the glycan database matching problem by providing comprehensive glycoprotein identification, including both peptide and glycan information, enhancing the accuracy and completeness of glycoprotein analysis.
Implementation Method 1
A first fragmentation device of the MS/MS that is adapted to fragment selected precursor ions using collision-induced dissociation (CID) is instructed to fragment the at least one precursor ion
Implementation Method 2
A second fragmentation device of the MS/MS that is adapted to fragment selected precursor ions from the second ion beam using electron-based dissociation (ExD) is instructed to fragment the at least one precursor ion
Implementation Method 3
The first ion beam is produced by an ion source device adapted to receive and ionize a sample that has been digested using a protease
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A mass isolation device selects a precursor ion of a sample that has been digested using a protease. A first fragmentation device fragments the precursor ion using collision-induced dissociation (CID), and the resulting product ions are analyzed using a mass analyzer producing a CID spectrum. A list of theoretical candidate glycopeptide sequences is determined from CID spectrum. The mass isolation device again selects the precursor ion of the sample. A second fragmentation device fragments the precursor ion using electron-based dissociation (ExD), and the resulting product ions are analyzed using the mass analyzer producing a CID spectrum. For each sequence of the list, the sequence is computationally fragmented, producing theoretical fragments, mass-to-charge ratio (m/z) values are calculated for the theoretical fragments, and the sequence is scored using c and z fragment matching rules. The highest scoring sequence is identified as a peptide sequence of a glycopeptide of the sample.